BioCentury | Jul 25, 2019
Product Development

The universe of universal flu vaccines

...1; NA - Influenza virus neuraminidase Only one of the other clinical candidates, FLU-v from Imutex Ltd....
...Md. Etubics Corp., Seattle, Wash. FluGen Inc., Madison, Wisc. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Imutex Ltd....
...Research & Analytics Arecor Ltd. BiondVax Pharmaceuticals Ltd. Blue Water Vaccines Inc. Codagenix Inc. CureVac N.V. Emergent BioSolutions Inc. Etubics Corp. FluGen Inc. GlaxoSmithKline plc Imutex Ltd. Inovio...
BioCentury | Jan 17, 2019
Clinical News

hVIVO reports Phase IIb data of universal flu vaccine

...2009 strain of H1N1 influenza A virus. hVIVO and Seek Ltd. (London, U.K.) formed JV Imutex Ltd....
BioCentury | Feb 22, 2018
Product R&D

Shooting for the universe

...a recombinant fusion protein from now defunct VaxInnate Corp., which reached Phase I/II testing. (A) Imutex Ltd....
...websites Company or Institute Product Modality Status BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) M-001 Peptide Phase II Imutex Ltd....
...be conducted in collaboration with NIH. Two candidates are in Phase II trials: FLU-v from Imutex Ltd....
BioCentury | Mar 31, 2017
Clinical News

AGS-v: Ph I started

...saliva, rather than a specific virus or parasite. Last year, hVIVO and Seek formed JV Imutex Ltd....
...biting and mosquito behavior Status: Phase I started Milestone: Complete Phase I (mid-2018) Alex Himes hVIVO plc Seek Ltd. AGS-v Imutex Ltd....
BioCentury | May 2, 2016
Company News

hVIVO, Seek Ltd. deal

...hVIVO and Seek will form JV Imutex Ltd. to develop vaccines against the flu and mosquito-borne diseases...
Items per page:
1 - 5 of 5
BioCentury | Jul 25, 2019
Product Development

The universe of universal flu vaccines

...1; NA - Influenza virus neuraminidase Only one of the other clinical candidates, FLU-v from Imutex Ltd....
...Md. Etubics Corp., Seattle, Wash. FluGen Inc., Madison, Wisc. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Imutex Ltd....
...Research & Analytics Arecor Ltd. BiondVax Pharmaceuticals Ltd. Blue Water Vaccines Inc. Codagenix Inc. CureVac N.V. Emergent BioSolutions Inc. Etubics Corp. FluGen Inc. GlaxoSmithKline plc Imutex Ltd. Inovio...
BioCentury | Jan 17, 2019
Clinical News

hVIVO reports Phase IIb data of universal flu vaccine

...2009 strain of H1N1 influenza A virus. hVIVO and Seek Ltd. (London, U.K.) formed JV Imutex Ltd....
BioCentury | Feb 22, 2018
Product R&D

Shooting for the universe

...a recombinant fusion protein from now defunct VaxInnate Corp., which reached Phase I/II testing. (A) Imutex Ltd....
...websites Company or Institute Product Modality Status BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) M-001 Peptide Phase II Imutex Ltd....
...be conducted in collaboration with NIH. Two candidates are in Phase II trials: FLU-v from Imutex Ltd....
BioCentury | Mar 31, 2017
Clinical News

AGS-v: Ph I started

...saliva, rather than a specific virus or parasite. Last year, hVIVO and Seek formed JV Imutex Ltd....
...biting and mosquito behavior Status: Phase I started Milestone: Complete Phase I (mid-2018) Alex Himes hVIVO plc Seek Ltd. AGS-v Imutex Ltd....
BioCentury | May 2, 2016
Company News

hVIVO, Seek Ltd. deal

...hVIVO and Seek will form JV Imutex Ltd. to develop vaccines against the flu and mosquito-borne diseases...
Items per page:
1 - 5 of 5